Kevin J. Basile

718 total citations
10 papers, 572 citations indexed

About

Kevin J. Basile is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Kevin J. Basile has authored 10 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Computational Theory and Mathematics. Recurrent topics in Kevin J. Basile's work include Melanoma and MAPK Pathways (7 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Cancer Cells and Metastasis (2 papers). Kevin J. Basile is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Cancer Cells and Metastasis (2 papers). Kevin J. Basile collaborates with scholars based in United States. Kevin J. Basile's co-authors include Ethan V. Abel, Andrew E. Aplin, Andrew E. Aplin, Struan F.A. Grant, Michele B. Weiss, Edward J. Hartsough, Adam C. Berger, Paolo Fortina, Matthew E. Johnson and Qianghua Xia and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Kevin J. Basile

10 papers receiving 571 citations

Peers

Countries citing papers authored by Kevin J. Basile

Since Specialization

Citations

This map shows the geographic impact of Kevin J. Basile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Basile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Basile more than expected).

Fields of papers citing papers by Kevin J. Basile

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Basile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Basile. The network helps show where Kevin J. Basile may publish in the future.

Co-authorship network of co-authors of Kevin J. Basile

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Basile. A scholar is included among the top collaborators of Kevin J. Basile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Basile. Kevin J. Basile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Beneficial Effects of RAF Inhibitor in Mutant BRAF Splice Variant–Expressing Melanoma 2014 ·Molecular Cancer Research ·Edward J. Hartsough, Kevin J. Basile, Andrew E. Aplin	19
2	Overlap of Genetic Susceptibility to Type 1 Diabetes, Type 2 Diabetes, and Latent Autoimmune Diabetes in Adults 2014 ·Current Diabetes Reports ·Kevin J. Basile, (unknown), Stanley S. Schwartz, Struan F.A. Grant	30
3	Genetic Susceptibility to Type 2 Diabetes and Obesity: Follow-Up of Findings from Genome-Wide Association Studies 2014 ·International Journal of Endocrinology ·Kevin J. Basile, Matthew E. Johnson, Qianghua Xia, Struan F.A. Grant	59
4	Inhibition of mutant BRAF splice variant signaling by next‐generation, selective RAF inhibitors 2014 ·Pigment Cell & Melanoma Research ·Kevin J. Basile, (unknown), Edward J. Hartsough, Andrew E. Aplin	39
5	In Vivo MAPK Reporting Reveals the Heterogeneity in Tumoral Selection of Resistance to RAF Inhibitors 2013 ·Cancer Research ·Kevin J. Basile, Ethan V. Abel, (unknown), Edward J. Hartsough, Paolo Fortina, Andrew E. Aplin	30
6	Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3 2013 ·Journal of Clinical Investigation ·Ethan V. Abel, Kevin J. Basile, Curtis H. Kugel, Agnieszka K. Witkiewicz, (unknown), Ravi K. Amaravadi, Giorgos C. Karakousis, Xiaowei Xu, Wei Xu, Lynn M. Schuchter, Jason B. Lee, Adam Ertel, Paolo Fortina, Andrew E. Aplin	189
7	TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells 2012 ·Cancer Research ·Michele B. Weiss, Ethan V. Abel, (unknown), Kevin J. Basile, Adam C. Berger, Andrew E. Aplin	124
8	Resistance to Chemotherapy 2012 ·Advances in pharmacology ·Kevin J. Basile, Andrew E. Aplin	14
9	Downregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cells. 2012 ·PubMed ·Kevin J. Basile, Andrew E. Aplin	16
10	Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells 2011 ·Oncogene ·Kevin J. Basile, Ethan V. Abel, Andrew E. Aplin	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact